FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013215549> ?p ?o ?g. }

• W3013215549 abstract "Abstract Objectives Iguratimod, a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective against murine lupus. The aim of this study was to make a preliminary evaluation of the efficacy and safety of iguratimod as salvage therapy in patients with refractory lupus nephritis (LN). Methods We enrolled eligible patients with refractory LN, which we defined as having failed or relapsed on at least two immunosuppressant agents. After enrollment, we substituted iguratimod (25 mg twice daily) for their previous immunosuppressant agents without increasing the dose of steroids. The primary outcome was complete/partial remission (PR/CR) at week 24. Patients who achieved remission continued iguratimod as maintenance therapy over an extended follow-up. Results The study cohort comprised 14 patients with refractory LN, 10 of whom had recent treatment failure and 4 repeated relapses with inadequate initial responses. At enrollment, none of the patients had detectable evidence of extra-renal involvement. The median prednisone dosage was 10 mg/d (IQR 0–10 mg/day). Thirteen patients were eligible for response evaluation, with one patient missed. The renal response rate was 92.3% (12/13) at week 24, with 38.5% (5/13) achieving CR and 53.8% (7/13) achieving PR. We then continued to follow up the responding patients for up to 144 weeks. Twenty-five percent of the patients (3/12) had renal relapse after initial PR. The estimated glomerular filtration rate of all patients maintained stable during follow-up. One patient had a severe adverse reaction (anemia) but recovered fully after stopping iguratimod. Conclusions Our study supports the potential of iguratimod for treatment of refractory LN. Iguratimod could be a promising candidate drug for this condition." @default.
• W3013215549 created "2020-04-03" @default.
• W3013215549 creator A5005480452 @default.
• W3013215549 creator A5011940207 @default.
• W3013215549 creator A5034417510 @default.
• W3013215549 creator A5036304210 @default.
• W3013215549 creator A5038238118 @default.
• W3013215549 creator A5038941379 @default.
• W3013215549 creator A5056353600 @default.
• W3013215549 creator A5061009939 @default.
• W3013215549 creator A5070902065 @default.
• W3013215549 creator A5075722707 @default.
• W3013215549 creator A5080922192 @default.
• W3013215549 date "2020-03-30" @default.
• W3013215549 modified "2023-10-18" @default.
• W3013215549 title "Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study" @default.
• W3013215549 cites W1984095586 @default.
• W3013215549 cites W1989273660 @default.
• W3013215549 cites W2005488007 @default.
• W3013215549 cites W2018455360 @default.
• W3013215549 cites W2018471518 @default.
• W3013215549 cites W2028198473 @default.
• W3013215549 cites W2066520348 @default.
• W3013215549 cites W2073246129 @default.
• W3013215549 cites W2076450964 @default.
• W3013215549 cites W2077056196 @default.
• W3013215549 cites W2082021143 @default.
• W3013215549 cites W2102288691 @default.
• W3013215549 cites W2119837784 @default.
• W3013215549 cites W2123632788 @default.
• W3013215549 cites W2130929166 @default.
• W3013215549 cites W2144635371 @default.
• W3013215549 cites W2155440550 @default.
• W3013215549 cites W2171121999 @default.
• W3013215549 cites W2540884398 @default.
• W3013215549 cites W2553726688 @default.
• W3013215549 cites W2558273348 @default.
• W3013215549 cites W2570355108 @default.
• W3013215549 cites W2787959687 @default.
• W3013215549 cites W2789147765 @default.
• W3013215549 cites W2796129073 @default.
• W3013215549 cites W2921255794 @default.
• W3013215549 cites W2927871970 @default.
• W3013215549 cites W2945302694 @default.
• W3013215549 cites W4251131605 @default.
• W3013215549 cites W4296086394 @default.
• W3013215549 doi "https://doi.org/10.1186/s13075-020-02154-7" @default.
• W3013215549 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7106733" @default.
• W3013215549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32228698" @default.
• W3013215549 hasPublicationYear "2020" @default.
• W3013215549 type Work @default.
• W3013215549 sameAs 3013215549 @default.
• W3013215549 citedByCount "11" @default.
• W3013215549 countsByYear W30132155492020 @default.
• W3013215549 countsByYear W30132155492021 @default.
• W3013215549 countsByYear W30132155492022 @default.
• W3013215549 countsByYear W30132155492023 @default.
• W3013215549 crossrefType "journal-article" @default.
• W3013215549 hasAuthorship W3013215549A5005480452 @default.
• W3013215549 hasAuthorship W3013215549A5011940207 @default.
• W3013215549 hasAuthorship W3013215549A5034417510 @default.
• W3013215549 hasAuthorship W3013215549A5036304210 @default.
• W3013215549 hasAuthorship W3013215549A5038238118 @default.
• W3013215549 hasAuthorship W3013215549A5038941379 @default.
• W3013215549 hasAuthorship W3013215549A5056353600 @default.
• W3013215549 hasAuthorship W3013215549A5061009939 @default.
• W3013215549 hasAuthorship W3013215549A5070902065 @default.
• W3013215549 hasAuthorship W3013215549A5075722707 @default.
• W3013215549 hasAuthorship W3013215549A5080922192 @default.
• W3013215549 hasBestOaLocation W30132155491 @default.
• W3013215549 hasConcept C121332964 @default.
• W3013215549 hasConcept C126322002 @default.
• W3013215549 hasConcept C141071460 @default.
• W3013215549 hasConcept C142424586 @default.
• W3013215549 hasConcept C159641895 @default.
• W3013215549 hasConcept C197934379 @default.
• W3013215549 hasConcept C198451711 @default.
• W3013215549 hasConcept C2776694085 @default.
• W3013215549 hasConcept C2776912625 @default.
• W3013215549 hasConcept C2777575956 @default.
• W3013215549 hasConcept C2778283404 @default.
• W3013215549 hasConcept C2778720950 @default.
• W3013215549 hasConcept C2779134260 @default.
• W3013215549 hasConcept C2779912601 @default.
• W3013215549 hasConcept C2780775027 @default.
• W3013215549 hasConcept C71924100 @default.
• W3013215549 hasConcept C72563966 @default.
• W3013215549 hasConcept C87355193 @default.
• W3013215549 hasConcept C90924648 @default.
• W3013215549 hasConceptScore W3013215549C121332964 @default.
• W3013215549 hasConceptScore W3013215549C126322002 @default.
• W3013215549 hasConceptScore W3013215549C141071460 @default.
• W3013215549 hasConceptScore W3013215549C142424586 @default.
• W3013215549 hasConceptScore W3013215549C159641895 @default.
• W3013215549 hasConceptScore W3013215549C197934379 @default.
• W3013215549 hasConceptScore W3013215549C198451711 @default.
• W3013215549 hasConceptScore W3013215549C2776694085 @default.
• W3013215549 hasConceptScore W3013215549C2776912625 @default.
• W3013215549 hasConceptScore W3013215549C2777575956 @default.
• W3013215549 hasConceptScore W3013215549C2778283404 @default.

• next